posted on 2025-07-02, 07:22authored byJoanna Domagala, Tomasz M. Grzywa, Iwona Baranowska, Magdalena Justyniarska, Ryan Tannir, Agnieszka Graczyk-Jarzynka, Aleksandra Kusowska, Maria Lecka, Marcin Poreba, Klaudyna Fidyt, Katsiaryna Marhelava, Zofia Pilch, Lea K. Picard, Tomasz Wegierski, Kamil Jastrzebski, Marta Krawczyk, Marta Klopotowska, Monika Granica, Doris Urlaub, Szymon Hajduk, Alexandra Neeser, Spencer Moros, Pawel Kozlowski, Malgorzata Bobrowicz, Marta Miaczynska, Leyuan Ma, Carsten Watzl, Magdalena Winiarska
<p>Ammonia decreases perforin levels and inhibits the cytotoxicity of CAR T cells. <b>A,</b> Viability of unmodified T cells and CD19 CAR T cells incubated with different concentrations of NH<sub>4</sub>Cl for 6 hours was assessed using propidium iodide staining and flow cytometry. Shown are data from technical replicates (<i>n</i> = 2). <b>B,</b> CD19 CAR T-cell cytotoxicity against Raji cells in the presence of different concentrations of NH<sub>4</sub>Cl. Cytotoxicity was determined after 6 hours using flow cytometry. Shown are data from technical replicates (<i>n</i> = 3). <b>C,</b> CD20 CAR T-cell cytotoxicity against luciferase-expressing CD20<sup>+</sup> Nalm6 cells in the presence of different concentrations of NH<sub>4</sub>Cl. Cytotoxicity was determined after 16 hours and normalized to CD20<sup>+</sup> Nalm6 cells without CAR T cells. Shown are data from one donor (<i>n</i> = 2). <b>D,</b> CD22 CAR T-cell cytotoxicity against luciferase-expressing Nalm6 cells in the presence of different concentrations of NH<sub>4</sub>Cl. Cytotoxicity was determined after 16 hours and normalized to Nalm6 cells without CAR T cells. Shown are data from one donor (<i>n</i> = 2). <b>E,</b> PD-L1 CAR T-cell cytotoxicity against luciferase-expressing PD-L1 knockout or PD-L1<sup>+</sup> MDA-MB-231 cells in the presence of different concentrations of NH<sub>4</sub>Cl. Cytotoxicity was determined after 16 hours and normalized to MDA-MB-231 cells without CAR T cells (<i>n</i> = 3). <b>F,</b> EGFRvIII CAR T-cell cytotoxicity against GFP-expressing EGFRvIII<sup>+</sup> U87 cells in the presence of different concentrations of NH<sub>4</sub>Cl. Cytotoxicity was measured using live-cell microscopy (IncuCyte) for 20 hours. Shown are data from one donor (<i>n</i> = 2). <b>G,</b> The level of perforin detected in human T cells stimulated with anti-CD3/CD28 and incubated with NH<sub>4</sub>Cl for 4 hours determined by intracellular staining using an anti-perforin antibody (δG9 clone) and flow cytometry (<i>n</i> = 4). MFI, mean fluorescence intensity. <b>H,</b> The level of total perforin in T cells stimulated with αCD3/CD28 and incubated with ammonia determined by Western blot methods using an anti-perforin antibody (Prf-344 clone). β-Actin is presented as a loading control. Representative blot from one donor is shown. <b>I,</b> Raji tumor–bearing mice were intratumorally injected with 5 × 10<sup>6</sup> human CD19 CAR T cells. After 4 hours, tumors were dissected and enzymatically dissociated, followed by CAR T-cell analysis for perforin levels using intracellular staining with an anti-perforin antibody (δG9 clone) and flow cytometry (<i>n</i> = 6). CD19 CAR T cells incubated with Raji cells for 4 hours in control medium <i>in vitro</i> were used as controls. <b>J,</b> Level of perforin protein in the CD8<sup>+</sup> T cells and NK cells in the blood and tumors of patients with HCC analyzed from a published dataset (<a href="#bib20" target="_blank">20</a>). <b>K,</b> Ammonia increases pH in secretory lysosomes, which results in the dissociation of perforin from proteoglycans. Subsequently, dissociated perforin is susceptible to inactivation and proteolytic degradation. Data show means ± SEM or median ±95% CI for <b>J</b>. <i>n</i> values are the number of biological replicates in <i>in vitro</i> experiments or the number of mice used to obtain the data. <b>K,</b> Created with BioRender.com. Winiarska, M. (2025) <a href="https://BioRender.com/t34e524" target="_blank">https://BioRender.com/t34e524</a>.</p>
Immunotherapy revolutionized cancer treatment in the last decade. Both NK cells and T cells are key components of host immunity against malignant cells that are being extensively investigated in the field of cancer immunotherapy. While approaches have been developed to improve the antitumor activity of NK and T cells, the tumor microenvironment remains an obstacle to effective NK and T‐cell–based therapies. Here, we demonstrated that cancer‐conditioned medium suppresses the antitumor activity of NK cells. Ammonia, a by‐product of cancer cell metabolism, accumulated in cancer‐conditioned medium and in the tumor microenvironment, and impaired the cytotoxicity of NK cells as well as the efficacy of antibody‐based and chimeric antigen receptor (CAR) NK and CAR T‐cell–based therapies in vitro. Ammonia induced NK and T‐cell dysfunction by decreasing the amount of mature perforin in secretory lysosomes, which was dependent on its lysosomotropic features and ability to increase pH in acidic compartments. These findings demonstrate that, in addition to its previously described role in promoting tumor growth as a source of nitrogen for tumor biomass, ammonia promotes tumor immune escape by inhibiting both NK and CAR T‐cell cytotoxicity.
Ammonia is elevated in the tumor microenvironment and functions as an immunoinhibitory metabolite in cancer by reducing perforin levels, inhibiting NK and T‐cell–mediated immunity and limiting the efficacy of immunotherapies.